Venrock Healthcare Capital Partners XP, L.P. — SEC insider filings
SEC reporting owner CIK 2037157. 4 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2026-10-22 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 12 legs across 3 filings — 2,078,749 shares, $38,522,394 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 1,944,444 shares @ $18.00 ($34,999,992) in Lycia Therapeutics, Inc., filed 2026-10-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lycia Therapeutics, Inc. (LYCA) | 10% owner | 4 | 12 legs · 2,078,749 sh · $38,522,394 | — | 3 |
Insider filings — Venrock Healthcare Capital Partners XP, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 8,305 @ $26.95 | EDGAR |
| 2026-10-30 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 10,570 @ $25.23 · Purchase (P): 4,430 @ $25.97 · Purchase (P): 1,000 @ $26.33 · Purchase (P): 8,804 @ $26.27 · Purchase (P): 200 @ $26.86 | EDGAR |
| 2026-10-27 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 24,560 @ $25.68 · Purchase (P): 28,379 @ $26.11 · Conversion (C): 4,779,793 · Purchase (P): 1,944,444 @ $18 · Purchase (P): 8,261 @ $26.97 · Purchase (P): 8,729 @ $25.84 · +3 more | EDGAR |
| 2026-10-22 | 3 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P | Holdings only — no transactions reported | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2037157 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs